CNTB - Company ID 0001835268
The table below shows Connect Biopharma Holdings Ltd's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $27.02M | $46.03M | $37.84M | $40.63M | $47.71M |
| Short-term investments | $4.47M | $0.00 | $16.94M | $31.14M | $36.29M |
| Receivables | $2.94M | $0.00 | $17.00K | $0.00 | $8.00K |
| Inventory | - | - | - | - | - |
| Total current assets | $38.62M | $55.02M | $62.60M | $77.76M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $87.75M |
| Property, plant & equipment | $3.60M | $3.70M | $3.94M | $4.05M | $3.91M |
| Goodwill | - | - | - | - | - |
| Total assets | $43.47M | $60.07M | $67.36M | $82.72M | $92.69M |
| Accounts payable | $2.02M | $4.31M | $1.99M | $2.29M | $817.00K |
| Total current liabilities | $16.30M | $17.05M | $11.43M | $10.74M | $8.56M |
| Long-term debt | - | - | - | - | - |
| Total liabilities | $16.61M | $17.44M | $11.99M | $11.38M | $9.79M |
| Retained earnings | -$437.52M | -$420.23M | -$385.73M | -$368.53M | -$355.63M |
| Total equity | $26.86M | $42.62M | $55.37M | $71.34M | $82.90M |